Israel Englander’s Pharvaris PHVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.8M Buy
427,403
+245,457
+135% +$7.43M 0.01% 1910
2026
Q1
$5.14M Sell
181,946
-66,912
-27% -$1.79M ﹤0.01% 2905
2025
Q4
$6.91M Buy
248,858
+142,310
+134% +$3.43M ﹤0.01% 2660
2025
Q3
$2.66M Buy
106,548
+93,263
+702% +$2.07M ﹤0.01% 3781
2025
Q2
$234K Buy
+13,285
New +$214K ﹤0.01% 5294
2025
Q1
Sell
-17,731
Closed -$340K 6282
2024
Q4
$340K Sell
17,731
-6,576
-27% -$135K ﹤0.01% 5000
2024
Q3
$450K Sell
24,307
-14,638
-38% -$267K ﹤0.01% 4915
2024
Q2
$732K Buy
38,945
+18,418
+90% +$375K ﹤0.01% 4339
2024
Q1
$474K Sell
20,527
-167,989
-89% -$4.46M ﹤0.01% 4866
2023
Q4
$5.29M Buy
+188,516
New +$3.81M ﹤0.01% 2742
2023
Q1
Sell
-10,286
Closed -$116K 6733
2022
Q4
$116K Sell
10,286
-100,380
-91% -$528K ﹤0.01% 5533
2022
Q3
$889K Buy
110,666
+28,712
+35% +$449K ﹤0.01% 4437
2022
Q2
$1.81M Sell
81,954
-26,432
-24% -$493K ﹤0.01% 3806
2022
Q1
$2.03M Sell
108,386
-11,172
-9% -$197K ﹤0.01% 3865
2021
Q4
$1.89M Sell
119,558
-38,195
-24% -$596K ﹤0.01% 3828
2021
Q3
$2.72M Sell
157,753
-39,214
-20% -$671K ﹤0.01% 3561
2021
Q2
$3.58M Sell
196,967
-33,933
-15% -$770K ﹤0.01% 3201
2021
Q1
$6.48M Buy
+230,900
New +$7.26M ﹤0.01% 2305

Other funds holding PHVS

Israel Englander's PHVS Position: Q2 2026 in Review

Israel Englander increased its Pharvaris (PHVS) stake by 135% in Q2 2026, buying an estimated $7.43M and bringing the position to 427,403 shares worth $14.8M. The position accounts for 0.01% of the portfolio, ranked #1910.

Israel Englander first reported a position in PHVS in Q1 2021 and has held it in 18 quarters since. 125 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

  • Israel Englander held 427,403 shares of Pharvaris worth $14.8M as of Q2 2026.
  • Israel Englander bought 245,457 Pharvaris shares in Q2 2026, an estimated $7.43M.
  • Pharvaris made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1910 holding.
  • Israel Englander first reported a position in Pharvaris in Q1 2021 and has held it in 18 quarters since.
  • 125 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.